Caricamento...
Membranoproliferative Glomerulonephritis Associated with Nivolumab Therapy
Nivolumab is an immune checkpoint inhibitor that targets programmed death-1 on T cells and is designed to amplify an immunologic reaction against cancer cells. However, upregulation of the immune system with checkpoint inhibition is nonspecific, and it can be associated with certain renal side effec...
Salvato in:
| Pubblicato in: | Case Rep Nephrol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Hindawi
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7060432/ https://ncbi.nlm.nih.gov/pubmed/32257470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2638283 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|